Clinical Trials
127 trialsIMCAN
University of Sunderland
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
TraveraRTGx
Travera Inc
MK-4700-001
Merck Sharp & Dohme LLC
Mobile App-Supported HPV and Breast Cancer Awareness Program
Ataturk University
LYSA
University College Cork
FORTITUDE-301
Amgen
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
Risen (Suzhou) Pharma Tech Co., Ltd.
AYAConnect
UNC Lineberger Comprehensive Cancer Center
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
New Mexico Cancer Research Alliance
EARN
Washington University School of Medicine
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Incyte Corporation
KEYVIBE-005
Merck Sharp & Dohme LLC
CNSI-Fe(II)
Sichuan Enray Pharmaceutical Sciences Company
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
AstraZeneca
P-COC
University of Alabama at Birmingham
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
Thomas Jefferson University
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
Exelixis
Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda
Brigham and Women's Hospital
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
RAPT Therapeutics, Inc.
Southeast Asian Women's Health Project
Ohio State University
MOVIE
UNICANCER
ROOT
Taproot Health
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Vincerx Pharma, Inc.
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Vincerx Pharma, Inc.
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
AstraZeneca
DUET-3
Xencor, Inc.
Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Gene Surgery LLC
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
OCEAP
Johns Hopkins University
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
MacroGenics
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Corvus Pharmaceuticals, Inc.
SEMM1
The University of Texas Health Science Center, Houston
Using a Lay Health Worker Program to Increase Breast and Cervical Cancer Screening in Low-Income Hispanic Women
The University of Texas Health Science Center, Houston
Ask Questions (ASQ):Implementation of a Communication Intervention
Barbara Ann Karmanos Cancer Institute
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Self-Advocacy Serious Game in Advanced Cancer
University of Pittsburgh
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Fate Therapeutics
DUET-4
Xencor, Inc.
Fractional CO2 Laser Therapy for Survivors of Breast Malignancies
Ohio State University Comprehensive Cancer Center
A Study of PRT1419 in Patients With Advanced Solid Tumors
Prelude Therapeutics
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
GASVERT
Institut de Cancérologie de Lorraine
DUET-2
Xencor, Inc.
A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab
Ludwig Institute for Cancer Research
Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
Roswell Park Cancer Institute
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Incyte Corporation
DEPISGYN
University Hospital, Montpellier
WiZen
Technische Universität Dresden